|
|
Volumn 1, Issue 3, 1999, Pages 301-302
|
|
Heart failure update
|
|
Author keywords
Clinical trial; Heart failure; Inotropic agent; Myocardial infarction
|
|
Indexed keywords
CALCIUM SENSITIZER;
INOTROPIC AGENT;
LEVOSIMENDAN;
PLACEBO;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CONTRAINDICATION;
HEART FAILURE;
HEART INFARCTION;
HUMAN;
HYPOTENSION;
MAJOR CLINICAL STUDY;
PATIENT SELECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SURVIVAL;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
BLOOD PRESSURE;
CARDIOTONIC AGENTS;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRAZONES;
MYOCARDIAL CONTRACTION;
MYOCARDIAL INFARCTION;
PYRIDAZINES;
SAFETY;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0033494240
PISSN: 13889842
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-9842(99)00040-9 Document Type: Short Survey |
|
Times cited : (20)
|
|
References (0)
|
